CAS 1527513-89-8

D9

CAS: 1527513-89-8

D9 is a monoclonal antibody that binds to the extracellular domain of the receptor for interleukin-2 (IL-2). It is used in research and development as an experimental drug candidate for the treatment of cancer. The binding of D9 to IL-2 prevents its interaction with IL-2 receptor and blocks IL-2 mediated signaling pathways, inhibiting the proliferation of cancer cells. D9 has also been shown to inhibit the production of monoamine neurotransmitters by binding to transcription factors. Small molecules such as D9 are often synthesized using chemical methods. These methods are typically carried out under acidic conditions, which may not be compatible with sensitive biological systems. It is also possible that D9 may be produced using recombinant methods or through fermentation.
D9 has been shown to have antimicrobial activity against various bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis, although it

Formula: C₂₅H₂₀AuOPS

Purity: Min. 95%

Molecular weight: 596.43 g/mol

Ref: 3D-FD172883

TrxR inhibitor D9

CAS: 1527513-89-8

TrxR-IN-D9 is a novel inhibitor of thioredoxin reductase (TrxR).

Formula: C₂₅H₂₀AuOPS

Color and Shape: Solid

Molecular weight: 596.43

Ref: TM-T29018